IGM Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. IGM Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 99% to $2,130,000. Profit margin reached -11569%. Total operating expenses were $265,591,000.
Profit Margin
| 2017 | 0 | -11.05M | |
|---|---|---|---|
| 2018 | 0 | -22.71M | |
| 2019 | 0 | -42.53M | |
| 2020 | 0 | -80.33M | |
| 2021 | 0 | -160.68M | |
| 2022 | 1.06M | -214.24M | -20041.91% |
| 2023 | 2.13M | -246.41M | -11568.83% |
IGMS Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 2.13M | 1.06M | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 8.27M | 10.60M | 7.72M | 3.57M | 2.33M | 0 | 161K |
Gross profit | -6.14M | -9.53M | -7.72M | -3.57M | -2.33M | 0 | -161K |
Operating exp. | |||||||
Research and development | 215.51M | 179.28M | 127.02M | 65.03M | 35.25M | 18.96M | 8.63M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 265.59M | 229.02M | 165.32M | 83.28M | 44.49M | 22.79M | 11.14M |
Operating income | -263.46M | -227.95M | -165.32M | -83.28M | -44.49M | -22.79M | -11.14M |
Other income (expenses), net | 17.72M | 6.85M | 159K | 1.92M | 1.36M | 80K | 93K |
Income before tax | -245.73M | -221.10M | -165.16M | -81.35M | -43.13M | -22.71M | -11.05M |
Income tax expense | 678K | -6.85M | -4.48M | -1.02M | -597K | 80K | 0 |
Net income | -246.41M | -214.24M | -160.68M | -80.33M | -42.53M | -22.71M | -11.05M |
Earnings per share | |||||||
Basic EPS | -4.71 | -5.16 | -4.8 | -2.61 | -4.73 | -51.84 | -25.24 |
Diluted EPS | -4.71 | -5.16 | -4.8 | -2.61 | -4.73 | -51.84 | -25.24 |
| Data source | Data source | Data source | Data source | Data source |